EU Report Puts Generics And Biosimilars In The Frame
EU Also Needs More Teamwork On Drug Pricing & Access
EU member states are being urged by the European Commission to cooperate more closely on pricing and reimbursement, managed access deals and policies to promote generics and biosimilars.
You may also be interested in...
AstraZeneca’s Lynparza can now be used on the Scottish National Health Service for newly diagnosed advanced ovarian cancer.
Amgen has received its fourth US biosimilar approval for its Avsola infliximab rival to Janssen’s Remicade.
As stockpiles of Ebola vaccine are being built up around the world, Médecins sans Frontières has said more action is needed to ensure sufficient numbers of vaccinations are available for use in current and future outbreaks.